Free Newsletter
Abbott Labs to cut 1,200 jobs
A new entrant into the layoff club is Abbott Laboratories, which says it's cutting 1,200 jobs in Ireland and California. Some 500 workers will be laid off from a stent-making factory in Galway, Ireland. Another 700 jobs will be cut from a facility in Temecula, California. Abbott employs about 65,000 people worldwide, so these layoffs represent less than 2 percent of its workforce. The company plans to take a charge against fourth-quarter earnings for the cuts.
The layoff announcement met with consternation in Ireland, where Abbott now employs about 3,400. Closing the Galway plant will have "major consequences" for the economy there, officials said, calling the layoffs there a "cruel blow." Some politicians called for the Irish government to invest in the Galway region to counteract the effects of the cuts; others want the government to reverse business-tax increases so that Ireland can attract more foreign investment.
- take a look at the report from the Chicago Tribune
- read this account of the local layoffs in The Irish Times
Related Articles:
Panel gives cautious OK to Abbott stent. Report
GE negotiating for Abbott diagnostics unit. Report
J&J sues Abbott to block new stent. Report
Top 5 layoffs of 2007. Report
Comments
Post new comment
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession






SHARE
WITH: